Ulcerative Colitis Clinical Trials in Miami, Florida

14 studies are recruiting for ulcerative colitis in Miami, Florida right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. A Study to Evaluate Efficacy and Safety of MK-8690 in Participants With Moderately to Severely Active Ulcerative Colitis (MK-8690-002)

   The purpose of this protocol is to evaluate the efficacy of MK-8690 in participants with moderately to severely active ulcerative colitis. The primary hypothesis is that MK-8690 is superior to placebo with respect to the proportion of participants achieving clinical remission per Modified Mayo Scor…

   Stage

   Phase 2

   Ages

   18 to 75

   Site

   Research Associates of South Florida - Miami - Southwest 8th Street ( Site 1072), Miami, Florida

   Locations

   35 in total

   Run by

   Merck Sharp & Dohme LLC

   See if you can join NCT07463183 on ClinicalTrials.gov

2. Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis

   Crohn's disease (CD) and Ulcerative colitis (UC) are 2 types of inflammatory bowel diseases which cause long-lasting, severe inflammation (redness, swelling) in the digestive tract. CD can affect any part of the digestive tract causing many different symptoms including belly pain, diarrhea, tiredne…

   Stage

   Phase 2

   Ages

   18 to 75

   Site

   Research Associates of South Florida /ID# 280929, Miami, Florida

   Locations

   36 in total

   Run by

   AbbVie

   See if you can join NCT07697456 on ClinicalTrials.gov

3. A Study to Learn More About How Risankizumab Works in Young Participants With Ulcerative Colitis

   Ulcerative colitis (UC) is a type of inflammatory bowel disease that causes inflammation and bleeding from the lining of the rectum and colon (large intestine). This study will assess how Risankizumab moves through the body as well as how safe and effective it is in treating pediatric participants …

   Stage

   Phase 3

   Ages

   2 to 17

   Site

   Nicklaus Children's Hospital - Miami - Southwest 62nd Avenue /ID# 271585, Miami, Florida

   Locations

   64 in total

   Run by

   AbbVie

   See if you can join NCT07071519 on ClinicalTrials.gov

4. A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting

   Ulcerative Colitis (UC) and Crohn's Disease (CD) are long-term conditions in the gut that can cause diarrhea, swelling (inflammation), bleeding from the anus, and belly pain. The main aim of this study is to check for how many participants with UC and CD signs and symptoms disappear after 3.5 month…

   Stage

   Phase 4

   Ages

   18 to 80

   Site

   Gastro Health Research - Miami, Miami, Florida

   Locations

   101 in total

   Run by

   Takeda

   See if you can join NCT06581328 on ClinicalTrials.gov

5. A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis

   This is a multicenter, randomized, double-blind, placebo-controlled Phase 3 maintenance study to evaluate the efficacy and safety of duvakitug in participants with moderately to severely active Ulcerative Colitis (UC). Study details include: The study duration may be up to 286 weeks including: * 40…

   Stage

   Phase 3

   Ages

   16 to 80

   Site

   Bioresearch Partner-Kendale Lakes - Site Number: 8400053, Miami, Florida

   Locations

   55 in total

   Run by

   Sanofi

   See if you can join NCT07185009 on ClinicalTrials.gov

6. Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study

   The main purpose of this study is to show whether in these individuals, treatment with both mirikizumab and tirzepatide, compared with treatment with mirikizumab and placebo, leads to decrease or disappearance of UC symptoms, and loss of at least one-tenth of the overall body weight. Participation …

   Stage

   Phase 3

   Ages

   18 to 70

   Site

   Research Associates of South Florida - Miami - Southwest 8th Street, Miami, Florida

   Locations

   187 in total

   Run by

   Eli Lilly and Company

   See if you can join NCT06937086 on ClinicalTrials.gov

7. A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis

   This is a Phase 2, multicenter, proof-of-concept platform study in adult participants with moderately to severely active ulcerative colitis (UC). The primary goal of the study is to assess the efficacy and safety of multiple interventions following intravenous (IV) induction and subcutaneous (SC) m…

   Stage

   Phase 2

   Ages

   18 to 75

   Site

   029, Miami, Florida

   Locations

   267 in total

   Run by

   Spyre Therapeutics, Inc.

   See if you can join NCT07012395 on ClinicalTrials.gov

8. A Study to Test Whether BI 3032950 Helps People With Ulcerative Colitis

   Adults between 18 and 80 years of age with ulcerative colitis can participate in this study. This is a study for people for whom previous treatment was not successful or who stopped previous treatment. The purpose of this study is to find out whether BI 3032950 helps people with ulcerative colitis.…

   Stage

   Phase 2

   Ages

   18 to 80

   Site

   University of Miami, Miami, Florida

   Locations

   41 in total

   Run by

   Boehringer Ingelheim

   See if you can join NCT06636656 on ClinicalTrials.gov

9. An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis

   This is a multinational, multicenter, randomized, double-blind, placebo-controlled, Phase 3 induction study to evaluate the efficacy and safety of duvakitug in participants with moderately to severely active Ulcerative Colitis (UC). Study details include: The study duration may be up to 35 weeks wi…

   Stage

   Phase 3

   Ages

   16 to 80

   Site

   Columbus Clinical Services LLc - Site Number: 8400038, Miami, Florida

   Locations

   219 in total

   Run by

   Sanofi

   See if you can join NCT07184996 on ClinicalTrials.gov

10. A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis

    The main purpose of this study is to determine the safety and efficacy of eltrekibart and mirikizumab in adult participants with moderately to severely active ulcerative colitis (UC).

    Stage

    Phase 2

    Ages

    18 to 75

    Site

    Well Pharma Medical Research Corp., Miami, Florida

    Locations

    207 in total

    Run by

    Eli Lilly and Company

    See if you can join NCT06598943 on ClinicalTrials.gov

11. R-3750 in Patients With Mild to Moderate Ulcerative Colitis

    The goal of this study is to determine the safety and tolerability of orally taken probiotic (R-3750) in patients with mild to moderate ulcerative colitis. Patients will take an oral dosage of probiotic (R-3750) and provide patient-reported and physician scored measures of their colitis. Blood and …

    Stage

    Phase 1

    Ages

    18 to 65

    Site

    AP Medical Research LLC, Miami, Florida

    Locations

    5 in total

    Run by

    Rise Therapeutics LLC

    See if you can join NCT05666960 on ClinicalTrials.gov

12. A Study to Investigate the Efficacy and Safety of SAR442970 in Adult Participants With Ulcerative Colitis

    This is a phase 2b, randomized, double-blind, 3-arm study for the treatment of Ulcerative Colitis. The primary objective of this study is to assess the efficacy of different doses of SAR442970 compared with placebo in participants with moderate to severe Ulcerative Colitis. The total study duration…

    Stage

    Phase 2

    Ages

    18 to 75

    Site

    Investigational Site Number: 8400001, Miami, Florida

    Locations

    67 in total

    Run by

    Sanofi

    See if you can join NCT06975722 on ClinicalTrials.gov

13. Tailored Anti-Inflammatory (A-I) Diet for Americans With Ulcerative Colitis (UC)

    The purpose of this study is to test the effect of an anti-inflammatory diet that incorporates native foods of the American diet on disease remission in American patients with Ulcerative Colitis (UC) and to identify biomarkers of response to dietary therapy.

    Stage

    Not phased

    Ages

    16 to 75

    Site

    University of Miami Health System, Miami, Florida

    Run by

    University of Miami

    See if you can join NCT06784323 on ClinicalTrials.gov

14. Hyperbaric Oxygen Therapy for Ulcerative Colitis (HBOT-UC)

    Chronic intestinal hypoxia and accompanying mucosal inflammation is a hallmark of ulcerative colitis (UC). Hyperbaric oxygen therapy (HBOT) involves breathing 100% oxygen under increased atmospheric pressure to increase tissue oxygenation. Two small prospective randomized controlled trials have dem…

    Stage

    Not phased

    Ages

    18 to 85

    Site

    University of Miami Health, Miami, Florida

    Locations

    13 in total

    Run by

    Northwestern University

    See if you can join NCT05987852 on ClinicalTrials.gov